These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States. Gupta R; Dhruva SS; Fox ER; Ross JS J Manag Care Spec Pharm; 2017 Oct; 23(10):1066-1076. PubMed ID: 28944731 [TBL] [Abstract][Full Text] [Related]
4. Vaccine shortages: history, impact, and prospects for the future. Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116 [TBL] [Abstract][Full Text] [Related]
5. The Impact of Shortages on Medication Prices: Implications for Shortage Prevention. Alevizakos M; Detsis M; Grigoras CA; Machan JT; Mylonakis E Drugs; 2016 Oct; 76(16):1551-1558. PubMed ID: 27770351 [TBL] [Abstract][Full Text] [Related]
6. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study. Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275 [TBL] [Abstract][Full Text] [Related]
7. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B; JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275 [TBL] [Abstract][Full Text] [Related]
8. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association. Tan L; Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133 [TBL] [Abstract][Full Text] [Related]
10. U.S. vaccine and immune globulin product shortages, 2001-15. Ziesenitz VC; Mazer-Amirshahi M; Zocchi MS; Fox ER; May LS Am J Health Syst Pharm; 2017 Nov; 74(22):1879-1886. PubMed ID: 28970246 [TBL] [Abstract][Full Text] [Related]
11. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences. Shrestha SS; Wallace GS; Meltzer MI Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451 [TBL] [Abstract][Full Text] [Related]
12. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs. Noah L S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891 [TBL] [Abstract][Full Text] [Related]
13. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance. Gilchrist SA; Nanni A Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880 [TBL] [Abstract][Full Text] [Related]
15. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions. Klein JO; Myers MG Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139 [TBL] [Abstract][Full Text] [Related]
16. Keys to strengthening the supply of routinely recommended vaccines: view from industry. Pisano W Clin Infect Dis; 2006 Mar; 42 Suppl 3():S111-7. PubMed ID: 16447131 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with the pricing of childhood vaccines in the U.S. public sector. Chen W; Messonnier M; Zhou F Health Econ; 2018 Feb; 27(2):252-265. PubMed ID: 28660666 [TBL] [Abstract][Full Text] [Related]
19. Setting prices for new vaccines (in advance). McGuire TG Int J Health Care Finance Econ; 2003 Sep; 3(3):207-24. PubMed ID: 14626000 [TBL] [Abstract][Full Text] [Related]
20. Vaccine supply: a cross-national perspective. Danzon PM; Pereira NS; Tejwani SS Health Aff (Millwood); 2005; 24(3):706-17. PubMed ID: 15886165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]